STI
19
2
ROK
43
3
TSCO
62
2
ORCL
65
2
HBAN
47
10
AVGO
44
9
C
58
3
PFG
59
6
USB
50
6
NKE
34
3
URBN
43
5
STT
37
4
OMC
55
2
TROW
34
7
GIS
37
3
CAH
40
2
MKC
56
2
IVZ
58
8
INTU
47
3
GRMN
48
3
STI
19
2
ROK
43
3
TSCO
62
2
ORCL
65
2
HBAN
47
10
AVGO
44
9
C
58
3
PFG
59
6
USB
50
6
NKE
34
3
URBN
43
5
STT
37
4
OMC
55
2
TROW
34
7
GIS
37
3
CAH
40
2
MKC
56
2
IVZ
58
8
INTU
47
3
GRMN
48
3
Financhill
Back

EyePoint Pharmaceuticals Stock Predictions

Invest in the Next Big AI Disruptor Today

Learn More
Sell
50

EYPT
EyePoint Pharmaceuticals

Last Price:
8.65
Seasonality Move:
-4.78%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Tech Innovator Poised for Strategic Buyouts Invest Now

Learn More

EyePoint Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 10.1% based on the past 19 years of stock performance.
  • EyePoint Pharmaceuticals has risen higher in 6 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 31.58%
  • Is EyePoint Pharmaceuticals Stock Undervalued?
    The current EyePoint Pharmaceuticals [EYPT] share price is $8.63. The Score for EYPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will EyePoint Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 10.1% based on the past 19 years of stock performance.

EyePoint Pharmaceuticals Stock Rating

Sell
50
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals overpriced?

  • EyePoint Pharmaceuticals has risen higher in 6 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 31.58%

EyePoint Pharmaceuticals Stock Price History

Is EYPT stock going to rise?

  • The current trend is relatively stagnant and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com

52-Week Data

52-Week High:
30.99
52-Week Low:
5.67

Prediction Charts

Market Cap:
461.86M
Price in USD:
8.63
Volume:
267.02K
Beta:
1.92

Technical Analysis

SMA50:
8.60
SMA100:
9.17
SMA200:
15.81
52-Wk Change:
8.96%

Stock Predictions

  • Is EyePoint Pharmaceuticals stock public?
    Yes, EyePoint Pharmaceuticals is a publicly traded company.
  • What is the EyePoint Pharmaceuticals stock quote today?
    The EyePoint Pharmaceuticals stock price is 8.63 USD today.
  • How to buy EyePoint Pharmaceuticals stock online?
    You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-17 8.92 8.78 9.12 8.70
Sep-18 8.73 8.91 9.33 8.62
Sep-19 9.25 9.18 9.61 9.09
Sep-20 9.11 8.92 9.33 8.49
Sep-23 8.93 8.29 8.93 8.20
Sep-24 8.31 8.34 8.52 8.21
Sep-25 8.33 8.15 8.58 7.90
Sep-26 8.28 8.07 8.36 7.97
Sep-27 8.21 7.98 8.29 7.91
Sep-30 7.94 7.99 8.40 7.93
Oct-1 7.94 8.01 8.05 7.78
Oct-2 7.98 8.21 8.37 7.88
Oct-3 8.14 8.37 8.39 8.00
Oct-4 8.50 8.63 8.70 8.29

EyePoint Pharmaceuticals Earnings

EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

EyePoint Pharmaceuticals Forecast Revenue Growth

EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.